Itm Solucin Gmbh

This program gives eligible patients with meningioma early access to the investigational drug ITM-11 before it is officially approved. A doctor will decide if the possible benefits outweigh the risks for each patient. The program is only available in certain countries.

This study tests a radioactive drug called Lu-177 edotreotide in children aged 2 to 17 with tumors that have a specific marker (SSTR). The goal is to find the right dose and check if it is safe. About 20 children whose tumors came back or did not respond to prior treatment will t…